瑞芯微(603893.SH):目前來看,終端客户端海外訂單同比在增加
格隆匯2月6日丨瑞芯微(603893.SH)在投資者互動平台表示,2023年,公司努力擴展海外市場和業務,增進與海外終端客户、代理商、方案商的配合,已觸達海外工業、消費、教育、辦公等各類應用場景,為全球客户提供優質的產品與解決方案。2024年,公司已參加了1月份舉辦的CES展,向眾多海外客户展示了瑞芯微在AIoT各行業的解決方案,擴大在海外市場的知名度。後續我們將加深與海外客户的交流與合作,全力推進更多項目落地,並繼續積極參加海外各個大型行業展會。目前來看,終端客户端海外訂單同比在增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.